{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:29:37Z","timestamp":1791430177571,"version":"4.3.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"S\u00f8rlandet Sykehus HF"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High somatic comorbidity is common among patients in treatment for opioid use disorder (OUD). The present study aims to investigate changes in self-reported somatic health conditions and somatic symptoms among patients entering opioid maintenance treatment (OMT) programs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used data from the Norwegian Cohort of Patients in OMT and Other Drug Treatment (NorComt) study. Of 283 patients who entered OMT, 176 were included for analysis at a 1-year follow-up. Participants provided self-reported data during structured interviews on somatic conditions, somatic symptoms, substance use severity measures, and mental distress. A multivariable linear regression analysis identified factors associated with changes in the burden of somatic symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients entering OMT reported a high prevalence of somatic conditions at the beginning of treatment, with 3 of 5 patients reporting at least one. The most prevalent condition was hepatitis C, followed by asthma and high blood pressure. Patients reported experiencing a high number of somatic symptoms. The intensity of these symptoms varied across a wide spectrum, with oral health complaints and reduced memory perceived as the most problematic. Overall, for the entire sample, there was no significant change in somatic symptoms from baseline to 1 year. Further analysis indicated that those who reported a higher burden of somatic symptoms at baseline had the greatest improvement at the 1-year follow-up. A higher number of somatic conditions and higher mental distress at baseline was associated with improvements in somatic symptoms burden at follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients in OMT report a range of somatic conditions and somatic symptoms. Given the wide range of symptoms reported by patients in OMT, including some at high intensity levels, healthcare providers should take into consideration the somatic healthcare needs of individuals in OMT populations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical trial registration<\/jats:title>\n                <jats:p>Clinicaltrials.gov no. NCT05182918. Registered 10\/01\/2022 (the study was retrospectively registered).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05590-w","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T15:03:38Z","timestamp":1708527818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Change in self-reported somatic symptoms among patients in opioid maintenance treatment from baseline to 1-year follow-up"],"prefix":"10.1186","volume":"24","author":[{"given":"Endre Dahlen","family":"Bj\u00f8rnestad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-K\u00e5re","family":"Vederhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"issue":"1","key":"5590_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell J, Strang J. Medication treatment of opioid Use Disorder. Biol Psychiatry. 2020;87(1):82\u20138.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"5590_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40263-020-00719-3","volume":"34","author":"E Kelty","year":"2020","unstructured":"Kelty E, Hulse G, Joyce D, Preen DB. Impact of pharmacological treatments for opioid Use Disorder on Mortality. CNS Drugs. 2020;34(6):629\u201342.","journal-title":"CNS Drugs"},{"issue":"12","key":"5590_CR3","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","volume":"24","author":"J Ma","year":"2019","unstructured":"Ma J, Bao Y-P, Wang R-J, Su M-F, Liu M-X, Li J-Q, Degenhardt L, Farrell M, Blow FC, Ilgen M, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868\u201383.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"5590_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo Jr","year":"2021","unstructured":"Santo T Jr, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran LT, Bharat C, Padmanathan P, et al. Association of Opioid Agonist Treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(9):979\u201393.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"5590_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000345229","volume":"19","author":"I Skeie","year":"2013","unstructured":"Skeie I, Brekke M, Clausen T, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, Waal H. Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study. Eur Addict Res. 2013;19(4):194\u2013201.","journal-title":"Eur Addict Res"},{"issue":"1","key":"5590_CR6","first-page":"80","volume":"34","author":"Z Gaulen","year":"2017","unstructured":"Gaulen Z, Alpers SE, Carlsen SL, Nesvag S. Health and social issues among older patients in opioid maintenance treatment in Norway. Nordisk Alkohol Nark. 2017;34(1):80\u201390.","journal-title":"Nordisk Alkohol Nark"},{"issue":"4","key":"5590_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/add.15705","volume":"117","author":"AB Bech","year":"2022","unstructured":"Bech AB, Clausen T, Waal H, Delaveris GJM, Skeie I. Organ pathologies detected post-mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation-wide 2-year cross-sectional study. Addiction. 2022;117(4):977\u201385.","journal-title":"Addiction"},{"issue":"5","key":"5590_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","volume":"77","author":"S Larney","year":"2020","unstructured":"Larney S, Tran LT, Leung J, Santo T Jr., Santomauro D, Hickman M, Peacock A, Stockings E, Degenhardt L. All-cause and cause-Specific Mortality among people using Extramedical opioids: a systematic review and Meta-analysis. JAMA Psychiatry. 2020;77(5):493\u2013502.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"5590_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00038-015-0698-3","volume":"60","author":"B Thylstrup","year":"2015","unstructured":"Thylstrup B, Clausen T, Hesse M. Cardiovascular disease among people with drug use disorders. Int J Public Health. 2015;60(6):659\u201368.","journal-title":"Int J Public Health"},{"issue":"1","key":"5590_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12888-022-04283-6","volume":"22","author":"ED Bj\u00f8rnestad","year":"2022","unstructured":"Bj\u00f8rnestad ED, Vederhus J-K, Clausen T. High smoking and low cessation rates among patients in treatment for opioid and other substance use disorders. BMC Psychiatry. 2022;22(1):649.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"5590_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/add.13099","volume":"111","author":"J Guydish","year":"2016","unstructured":"Guydish J, Passalacqua E, Pagano A, Martinez C, Le T, Chun J, Tajima B, Docto L, Garina D, Delucchi K. An international systematic review of smoking prevalence in addiction treatment. Addiction. 2016;111(2):220\u201330.","journal-title":"Addiction"},{"issue":"1","key":"5590_CR12","doi-asserted-by":"publisher","first-page":"e000130","DOI":"10.1136\/bmjopen-2011-000130","volume":"1","author":"I Skeie","year":"2011","unstructured":"Skeie I, Brekke M, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, Waal H. Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study. BMJ Open. 2011;1(1):e000130.","journal-title":"BMJ Open"},{"key":"5590_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.drugalcdep.2019.01.019","volume":"197","author":"L Gao","year":"2019","unstructured":"Gao L, Robertson JR, Bird SM. Non drug-related and opioid-specific causes of 3262 deaths in Scotland\u2019s methadone-prescription clients, 2009\u20132015. Drug Alcohol Depend. 2019;197:262\u201370.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"5590_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000525694","volume":"28","author":"I Skeie","year":"2022","unstructured":"Skeie I, Clausen T, Hjems\u00e6ter AJ, Landheim AS, Monsbakken B, Thoresen M, Waal H. Mortality, causes of death, and predictors of death among patients on and off opioid agonist treatment: results from a 19-Year Cohort Study. Eur Addict Res. 2022;28(5):358\u201367.","journal-title":"Eur Addict Res"},{"issue":"1","key":"5590_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12913-019-4282-z","volume":"19","author":"AB Bech","year":"2019","unstructured":"Bech AB, Clausen T, Waal H, \u0160altyt\u0117 Benth J, Skeie I. Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study. BMC Health Serv Res. 2019;19(1):440.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5590_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13011-020-00311-4","volume":"15","author":"D Medved","year":"2020","unstructured":"Medved D, Clausen T, Bukten A, Bj\u00f8rnestad R, Muller AE. Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients. Subst Abuse Treat Prev Policy. 2020;15(1):87.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"5590_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1186\/s12913-022-08351-1","volume":"22","author":"T Vikbladh","year":"2022","unstructured":"Vikbladh T, Troberg K, H\u00e5kansson A, Dahlman D. Healthcare utilization for somatic conditions among Swedish patients in opioid substitution treatment, with and without on-site primary healthcare. BMC Health Serv Res. 2022;22(1):971.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"5590_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/add.14892","volume":"115","author":"D Lewer","year":"2020","unstructured":"Lewer D, Freer J, King E, Larney S, Degenhardt L, Tweed EJ, Hope VD, Harris M, Millar T, Hayward A, et al. Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis. Addiction. 2020;115(6):1011\u201323.","journal-title":"Addiction"},{"issue":"1","key":"5590_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13011-022-00434-w","volume":"17","author":"K Troberg","year":"2022","unstructured":"Troberg K, Lundqvist K, Hansson H, H\u00e5kansson A, Dahlman D. Healthcare seeking among Swedish patients in opioid substitution treatment\u2013 a mixed methods study on barriers and facilitators. Subst Abuse Treat Prev Policy. 2022;17(1):8.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"5590_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13011-020-00309-y","volume":"15","author":"CF Aas","year":"2020","unstructured":"Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, Askildsen JE, Loberg EM, Fadnes LT, Johansson KA, et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy. 2020;15(1):68.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1\u20132","key":"5590_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2012.08.003","volume":"128","author":"L Dhingra","year":"2013","unstructured":"Dhingra L, Masson C, Perlman DC, Seewald RM, Katz J, McKnight C, Homel P, Wald E, Jordan AE, Young C, et al. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013;128(1\u20132):161\u20135.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"5590_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4088\/JCP.08m04367","volume":"70","author":"DT Barry","year":"2009","unstructured":"Barry DT, Beitel M, Garnet B, Joshi D, Rosenblum A, Schottenfeld RS. Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry. 2009;70(9):1213\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"5590_CR23","first-page":"72","volume":"34","author":"HT Nyhagen","year":"2017","unstructured":"Nyhagen HT, Waal H. Den Aldrende LAR pasienten. Nordisk Alkohol Nark. 2017;34(1):72\u20139.","journal-title":"Nordisk Alkohol Nark"},{"key":"5590_CR24","unstructured":"Linda Nesse P, Lobmaier I, Skeie P\u00e5lH, Lillevold, Thomas Clausen. Statusrapport 2022: F\u00f8rste \u00e5r med nye LAR-retningslinjer (Annual report 2022. In. Oslo: Universitet i Oslo,; 2023."},{"key":"5590_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2017.10.007","volume":"182","author":"AM Carew","year":"2018","unstructured":"Carew AM, Comiskey C. Treatment for opioid use and outcomes in older adults: a systematic literature review. Drug Alcohol Depend. 2018;182:48\u201357.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"5590_CR26","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/01612840.2015.1081655","volume":"36","author":"A Searby","year":"2015","unstructured":"Searby A, Maude P, McGrath I. An Ageing Methadone Population: a challenge to aged persons\u2019 Mental Health services? Iss Ment Health Nurs. 2015;36(11):927\u201331.","journal-title":"Iss Ment Health Nurs"},{"key":"5590_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12955-016-0439-1","volume":"14","author":"AE Muller","year":"2016","unstructured":"Muller AE, Skurtveit S, Clausen T. Many correlates of poor quality of life among substance users entering treatment are not addiction-specific. Health Qual Life Outcomes. 2016;14:39.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"5590_CR28","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1080\/10826084.2017.1413114","volume":"53","author":"KF Abel","year":"2018","unstructured":"Abel KF, Skj\u00e6rv\u00f8 I, Ravndal E, Clausen T, Bramness JG. Perceived self-control is related to Mental Distress in patients entering Substance Use Disorder Treatment. Subst Use Misuse. 2018;53(9):1454\u201362.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"5590_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12888-021-03518-2","volume":"21","author":"I Skj\u00e6rv\u00f8","year":"2021","unstructured":"Skj\u00e6rv\u00f8 I, Clausen T, Skurtveit S, Bukten A. Desistance from crime following substance use treatment: the role of treatment retention, social network and self-control. BMC Psychiatry. 2021;21(1):563.","journal-title":"BMC Psychiatry"},{"key":"5590_CR30","unstructured":"The Norwegian Directorate of Health (Helsedirektoratet): Nasjonal faglig retningslinje for legemiddelassistert rehabilitering (LAR) ved opioidavhengighet (National guideline for medication assisted treatment for opioid dependence). In., vol. 2022. Oslo: Helsedirektoratet; 2022."},{"issue":"6","key":"5590_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jpsychores.2013.03.093","volume":"74","author":"WL Zijlema","year":"2013","unstructured":"Zijlema WL, Stolk RP, L\u00f6we B, Rief W, White PD, Rosmalen JG. How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom Res. 2013;74(6):459\u201368.","journal-title":"J Psychosom Res"},{"issue":"4","key":"5590_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JB, L\u00f6we B. The Patient Health Questionnaire somatic, anxiety, and depressive Symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"5590_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607\u201314.","journal-title":"Addiction"},{"key":"5590_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.addbeh.2018.10.046","volume":"90","author":"DM Ledgerwood","year":"2019","unstructured":"Ledgerwood DM, Lister JJ, LaLiberte B, Lundahl LH, Greenwald MK. Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients. Addict Behav. 2019;90:191\u20135.","journal-title":"Addict Behav"},{"key":"5590_CR35","unstructured":"EMCDDA. Trends in injecting drug use in Europe. In.: European Monitoring Centre for Drugs and Drug Addiction; 2010."},{"key":"5590_CR36","doi-asserted-by":"crossref","unstructured":"Andreas JB, Lauritzen G, Nordfjaern T. Co-occurrence between mental distress and poly-drug use: a ten year prospective study of patients from substance abuse treatment. Addict Behav. 2015;48:71\u20138.","DOI":"10.1016\/j.addbeh.2015.05.001"},{"key":"5590_CR37","doi-asserted-by":"crossref","unstructured":"Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1\u201315.","DOI":"10.1002\/bs.3830190102"},{"issue":"7139","key":"5590_CR38","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV. What\u2019s wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236\u20138.","journal-title":"BMJ"},{"issue":"8","key":"5590_CR39","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1183\/09031936.97.10081795","volume":"10","author":"C Janson","year":"1997","unstructured":"Janson C, Chinn S, Jarvis D, Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J. 1997;10(8):1795\u2013802.","journal-title":"Eur Respir J"},{"key":"5590_CR40","unstructured":"Lobmaier P, Skeie I, Lillevold P, Waal H, Bussesund K, Clausen T. Statusrapport 2019: Nye medisiner - nye muligheter? (Annual report 2019). In.; 2020."},{"issue":"1","key":"5590_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12879-017-2631-2","volume":"17","author":"H Meijerink","year":"2017","unstructured":"Meijerink H, White RA, L\u00f8vlie A, de Blasio BF, Dalgard O, Amundsen EJ, Melum E, Kl\u00f8vstad H. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973\u20132030. BMC Infect Dis. 2017;17(1):541.","journal-title":"BMC Infect Dis"},{"key":"5590_CR42","unstructured":"Folkehelseinstituttet. Statusrapport om eliminasjon av hepatitt B og C som folkehelseproblem i Norge [Status report on the elimination of hepatitis B and C as a public health threat in Norway]. In. Oslo: Folkehelseinstituttet; 2023."},{"issue":"8","key":"5590_CR43","doi-asserted-by":"publisher","first-page":"e036355","DOI":"10.1136\/bmjopen-2019-036355","volume":"10","author":"CF Aas","year":"2020","unstructured":"Aas CF, Vold JH, Skurtveit S, Odsbu I, Chalabianloo F, \u00d8kland JM, Leiva RAM, Vickerman P, Johansson KA, Fadnes LT. On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017. BMJ Open. 2020;10(8):e036355.","journal-title":"BMJ Open"},{"issue":"23","key":"5590_CR44","doi-asserted-by":"publisher","first-page":"15732","DOI":"10.3390\/ijerph192315732","volume":"19","author":"KT S\u00e6l\u00f8r","year":"2022","unstructured":"S\u00e6l\u00f8r KT, Carlsen S-EL, Fadnes LT, Lor\u00e5s L. Experiences of Hope after Treatment of Hepatitis C Infection - A qualitative study. Int J Environ Res Public Health. 2022;19(23):15732.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5590_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cre2.476","volume":"8","author":"AN \u00c5str\u00f8m","year":"2022","unstructured":"\u00c5str\u00f8m AN, Virtanen J, \u00d6zkaya F, Fadnes LT. Oral health related quality of life and reasons for non-dental attendance among patients with substance use disorders in withdrawal rehabilitation. Clin Exp Dent Res. 2022;8(1):68\u201375.","journal-title":"Clin Exp Dent Res"},{"issue":"1","key":"5590_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13011-021-00379-6","volume":"16","author":"S-EL Carlsen","year":"2021","unstructured":"Carlsen S-EL, Isaksen K, Fadnes LT, Lygren OJS, \u00c5str\u00f8m AN. Non-financial barriers in oral health care: a qualitative study of patients receiving opioid maintenance treatment and professionals\u2019 experiences. Subst Abuse Treat Prev Policy. 2021;16(1):44.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"5590_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/add.15636","volume":"117","author":"K Herlinger","year":"2022","unstructured":"Herlinger K, Lingford-Hughes A. Opioid use disorder and the brain: a clinical perspective. Addiction. 2022;117(2):495\u2013505.","journal-title":"Addiction"},{"key":"5590_CR48","doi-asserted-by":"publisher","first-page":"106752","DOI":"10.1016\/j.addbeh.2020.106752","volume":"114","author":"JJ Mahoney","year":"2021","unstructured":"Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead M, Wen S, et al. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addict Behav. 2021;114:106752.","journal-title":"Addict Behav"},{"issue":"8","key":"5590_CR49","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","volume":"33","author":"HH Brorson","year":"2013","unstructured":"Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010\u201324.","journal-title":"Clin Psychol Rev"},{"issue":"10","key":"5590_CR50","first-page":"1837","volume":"18","author":"S M\u00fcller-Lissner","year":"2017","unstructured":"M\u00fcller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, Emmanuel A, Laroche F, Meissner W, Morlion B. Opioid-Induced Constipation and Bowel Dysfunction: a clinical Guideline. Pain Med. 2017;18(10):1837\u201363.","journal-title":"Pain Med"},{"issue":"4","key":"5590_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/ajad.13153","volume":"30","author":"Z-EH Latif","year":"2021","unstructured":"Latif Z-EH, Skj\u00e6rv\u00f8 I, Solli KK, Tanum L. Chronic Pain among patients with an opioid use disorder. Am J Addict. 2021;30(4):366\u201375.","journal-title":"Am J Addict"},{"key":"5590_CR52","doi-asserted-by":"crossref","unstructured":"Carlsen S-EL, Fadnes LT, Napsholm BU, Lor\u00e5s L. Perceived Change in Quality of Life Related to Treatment of Hepatitis C Infection among People with Substance Use Disorder: A Qualitative Study. Health & Social Care in the Community 2023, 2023:4073080.","DOI":"10.1155\/2023\/4073080"},{"issue":"12","key":"5590_CR53","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/imj.12298","volume":"43","author":"MM Islam","year":"2013","unstructured":"Islam MM, Taylor A, Smyth C, Day CA. General health of opioid substitution therapy clients. Intern Med J. 2013;43(12):1335\u20138.","journal-title":"Intern Med J"},{"key":"5590_CR54","unstructured":"The Norwegian Directorate of Health (Helsedirektoratet).: Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet (National guideline for medication assisted treatment for opioid dependence). In. Oslo: The Norwegian Directorate of Health (Helsedirektoratet); 2010."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05590-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05590-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T22:03:11Z","timestamp":1708552991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05590-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5590"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05590-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by The Regional Committee for Research Ethics in Norway, REC South East C (ref: REK 2012\/1131). All methods were used in accordance with relevant guidelines and regulations, and written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}